206 related articles for article (PubMed ID: 33580614)
1. Prognostic values and immune suppression of the S100A family in pancreatic cancer.
Zhuang H; Chen X; Dong F; Zhang Z; Zhou Z; Ma Z; Huang S; Chen B; Zhang C; Hou B
J Cell Mol Med; 2021 Mar; 25(6):3006-3018. PubMed ID: 33580614
[TBL] [Abstract][Full Text] [Related]
2. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
4. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells.
Xu X; Su B; Xie C; Wei S; Zhou Y; Liu H; Dai W; Cheng P; Wang F; Xu X; Guo C
PLoS One; 2014; 9(7):e96441. PubMed ID: 25072505
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
6. An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer.
Zeng ML; Zhu XJ; Liu J; Shi PC; Kang YL; Lin Z; Cao YP
Biomed Res Int; 2020; 2020():4746929. PubMed ID: 33294444
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study.
Xu HY; Song HM; Zhou Q
Medicine (Baltimore); 2020 Nov; 99(47):e22777. PubMed ID: 33217795
[TBL] [Abstract][Full Text] [Related]
9. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of S100 family members in ovarian cancer patients.
Bai Y; Li LD; Li J; Lu X
BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.
Zheng S; Liu L; Xue T; Jing C; Xu X; Wu Y; Wang M; Xie X; Zhang B
Front Genet; 2021; 12():648156. PubMed ID: 33815482
[TBL] [Abstract][Full Text] [Related]
12. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
13. Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.
Hatoum D; Yagoub D; Ahadi A; Nassif NT; McGowan EM
PLoS One; 2017; 12(1):e0169925. PubMed ID: 28068434
[TBL] [Abstract][Full Text] [Related]
14. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
Front Immunol; 2021; 12():758004. PubMed ID: 34887861
[TBL] [Abstract][Full Text] [Related]
15. S100 family signaling network and related proteins in pancreatic cancer (Review).
Ji YF; Huang H; Jiang F; Ni RZ; Xiao MB
Int J Mol Med; 2014 Apr; 33(4):769-76. PubMed ID: 24481067
[TBL] [Abstract][Full Text] [Related]
16. FAM83H overexpression predicts worse prognosis and correlates with less CD8
Zhuang H; Zhang C; Hou B
Clin Transl Oncol; 2020 Dec; 22(12):2244-2252. PubMed ID: 32424701
[TBL] [Abstract][Full Text] [Related]
17. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
18. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
[TBL] [Abstract][Full Text] [Related]
19. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.
Zhuang H; Chen X; Wang Y; Huang S; Chen B; Zhang C; Hou B
Cancer Immunol Immunother; 2022 Mar; 71(3):601-612. PubMed ID: 34279685
[TBL] [Abstract][Full Text] [Related]
20. S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.
Zhang C; Yao R; Chen J; Zou Q; Zeng L
Medicine (Baltimore); 2021 Jan; 100(3):e24135. PubMed ID: 33546025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
